Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T9JW
|
|||
Drug Name |
AU101
|
|||
Indication | Osteosarcoma [ICD-11: 2B51; ICD-9: 170] | Phase 1/2 | [1], [2] | |
Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] | Phase 1/2 | [2], [3] | ||
Recurring respiratory infection [ICD-11: CA07-CA45; ICD-10: J01.81] | Phase 1/2 | [1] | ||
Sarcoma [ICD-11: 2A60-2C35; ICD-10: C81-C86; ICD-9: 202.8] | Phase 1/2 | [1] | ||
Company |
Aurora BioPharma Cambridge, MA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | T-cell-specific surface glycoprotein CD28 (CD28) | Target Info | Immunomodulator | [1] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
T cell receptor signaling pathway | ||||
Intestinal immune network for IgA production | ||||
Type I diabetes mellitus | ||||
Measles | ||||
Autoimmune thyroid disease | ||||
Systemic lupus erythematosus | ||||
Rheumatoid arthritis | ||||
Allograft rejection | ||||
Graft-versus-host disease | ||||
Viral myocarditis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | T cell activation | |||
Pathway Interaction Database | TCR signaling in naï | |||
TCR signaling in naï | ||||
IL12 signaling mediated by STAT4 | ||||
Reactome | PIP3 activates AKT signaling | |||
Constitutive Signaling by Aberrant PI3K in Cancer | ||||
CD28 co-stimulation | ||||
CD28 dependent PI3K/Akt signaling | ||||
CD28 dependent Vav1 pathway | ||||
WikiPathways | TCR Signaling Pathway | |||
Inflammatory Response Pathway | ||||
Host Interactions of HIV factors | ||||
PIP3 activates AKT signaling | ||||
T-Cell Receptor and Co-stimulatory Signaling | ||||
Allograft Rejection | ||||
Costimulation by the CD28 family |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.